The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Use a concentration of 0.5 - 1 µg/ml. Predicted molecular weight: 60 kDa.
FunctionResponsible for the regulation of fatty acid synthesis by phosphorylation of acetyl-CoA carboxylase. It also regulates cholesterol synthesis via phosphorylation and inactivation of hormone-sensitive lipase and hydroxymethylglutaryl-CoA reductase. Appears to act as a metabolic stress-sensing protein kinase switching off biosynthetic pathways when cellular ATP levels are depleted and when 5'-AMP rises in response to fuel limitation and/or hypoxia. This is a catalytic subunit.
Sequence similaritiesBelongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. SNF1 subfamily. Contains 1 protein kinase domain.
5 AMP activated protein kinase alpha 1catalytic subunit antibody
5 AMP activated protein kinase catalytic alpha 1 chain antibody
5' AMP activated protein kinase catalytic subunit alpha 1 antibody
5'-AMP-activated protein kinase catalytic subunit alpha-1 antibody
ACACA kinase antibody
acetyl CoA carboxylase kinase antibody
AMP -activate kinase alpha 1 subunit antibody
AMP-activated protein kinase, catalytic, alpha -1 antibody
AMPK 1 antibody
AMPK alpha 1 antibody
AMPK alpha 1 chain antibody
AMPK subunit alpha-1 antibody
EC 126.96.36.199 antibody
HMG CoA reductase kinase antibody
HMGCR kinase antibody
hormone sensitive lipase kinase antibody
Hydroxymethylglutaryl CoA reductase kinase antibody
kinase AMPK alpha1 antibody
PRKAA 1 antibody
Protein kinase AMP activated alpha 1 catalytic subunit antibody
SNF1-like protein AMPK antibody
Tau protein kinase PRKAA1 antibody
Anti-AMPK alpha 1 antibody - Aminoterminal end images
Western blot - AMPK alpha 1 antibody (ab49656)
Lanes 1 - 3 : Anti-AMPK alpha 1 antibody - Aminoterminal end (ab49656) at 1/4000 dilution Lane 4 : Anti-AMPK alpha 1 antibody - Aminoterminal end (ab49656) at 1/8000 dilution Lane 5 : Anti-AMPK alpha 1 antibody - Aminoterminal end (ab49656) at 1/10000 dilution
Lane 1 : undifferentiated embryonic 3T3-L1 cells Lane 2 : 3T3-L1 differentiated into adipocytes by treatment with dexamethasone and insulin.
with Inhibition with AMPKa (human 2-19) immunizing peptide.
at 20 µg/ml Lane 3 : 3T3-L1 differentiated into adipocytes by treatment with dexamethasone and insulin.
Lane 4 : 3T3-L1 differentiated into adipocytes by treatment with dexamethasone and insulin.
Lane 5 : 3T3-L1 differentiated into adipocytes by treatment with dexamethasone and insulin.
Secondary HRP conjugated Goat Anti-Rabbit IgG
Predicted band size : 60 kDa Observed band size : 60 kDa
References for Anti-AMPK alpha 1 antibody - Aminoterminal end (ab49656)
has not yet been referenced specifically in any publications.
Publishing research using ab49656? Please let us know so that we can cite the reference in this datasheet.
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"